PT - JOURNAL ARTICLE AU - Wang, Yanfei AU - Song, Ke AU - Cai, Songlin AU - Wu, Weifei TI - A Meta-analysis of the efficacy of topical antibiotics in spinal surgery for the prevention of surgical site infection AID - 10.1101/2024.04.18.24305937 DP - 2024 Jan 01 TA - medRxiv PG - 2024.04.18.24305937 4099 - http://medrxiv.org/content/early/2024/04/19/2024.04.18.24305937.short 4100 - http://medrxiv.org/content/early/2024/04/19/2024.04.18.24305937.full AB - Background Despite significant advancements in clinical aseptic techniques and wound infection control, surgical site infections (SSIs) continue to pose a significant risk and complication following spinal surgery. The use of intrawound antibiotics for the prevention of SSIs after spine surgery is a controversial method.Objective To conduct a review of the current literature on the use of antibiotics in wound care and evaluate their effectiveness in preventing postoperative SSIs.Methods Keywords such as “spinal surgery” or “spine”, “antibiotics”, “local” or “topical”, “prevention of infection”, and “infection” were used based on PubMed, Web of Science, Cochrane and Embase database. The literature was screened based on the title, abstract, full text reading, and extraction of relevant research data. Comparisons of the data were performed using RevMan 5.3 software.Results A total of 18922 patients from 24 studies were included in the final analysis, 8878 patients received antibiotics (experimental group) to prevent SSIs, and 10044 patients did not receive any additional antibiotics (control group). In the experimental group, 178 patients developed SSIs, compared to 356 patients in the control group. The results of the meta-analysis indicated that the incidence of SSIs in the experimental group was significant lower than that in the control group (95% confidence interval, 0.36-0.75, p=0.0004).Conclusion The topical application of antibiotics within the wound site is a crucial and efficient method to prevent SSIs after spinal surgery.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported by National Natural Science Foundation of Hubei province (2023AFB1006) and Hubei Provincial Health Commission Young Talent Programme (WJ2023Q020).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data generated or analyzed during this study are included in this article.